P
ZURA icon

Pfizer’s Zura Bio ZURA Stock Holding History

Pfizer’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Sell
538,841
-2,300,072
-81% -$11M 1.69% 12
2026
Q1 		$16.8M Sell
2,838,913
-131,109
-4% -$792K 7.05% 5
2025
Q4 		$15.6M Hold
2,970,022
– – 6.58% 6
2025
Q3 		$12.9M Hold
2,970,022
– – 2.94% 9
2025
Q2 		$3.12M Hold
2,970,022
– – 0.54% 13
2025
Q1 		$3.83M Hold
2,970,022
– – 0.77% 11
2024
Q4 		$7.43M Buy
+2,970,022
New +$10.6M 0.29% 13

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Pfizer's ZURA Position: Q2 2026 in Review

Pfizer reduced its Zura Bio (ZURA) stake by 81% in Q2 2026, selling an estimated $11M and leaving 538,841 shares worth $2.88M. The position accounts for 1.69% of the portfolio, ranked #12.

Pfizer first reported a position in ZURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.8M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Pfizer held 538,841 shares of Zura Bio worth $2.88M as of Q2 2026.
  • Pfizer sold 2,300,072 Zura Bio shares in Q2 2026, an estimated $11M.
  • Zura Bio made up 1.69% of Pfizer's portfolio in Q2 2026, its #12 holding.
  • Pfizer first reported a position in Zura Bio in Q4 2024 and has held it in 7 quarters since.
  • Pfizer's Zura Bio position peaked at $16.8M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.